Posts Tagged ‘prothrombin 20210 mutation’
Stephan Moll, MD writes… The decision how long to treat a patient who has had a DVT or PE with blood thinners can often be made based just on the patient’s history. Often no testing for clotting disorders (thrombophilias) is needed. The decision how long to treat is influenced by 3 factors: (1) What is the person’s risk of another clot if he/she is not on blood thinners any more? (2) What is the person’s risk for bleeding on blood thinners? (3) What is the person’s own preference regarding his/her treatment. These issues are discussed in detail here.
However, if one were to do testing, what is the right time to test? It is important to know that some blood thinners can influence test results.
Liz Varga, Certified Genetic Counselor, Nationwide Children’s Hospital, Columbus OH writes….
Some people may have concerns about genetic testing for clotting disorders (thrombophilias) for fear of genetic discrimination. Fortunately in the United States, we have laws in place that can alleviate this concern. Read the rest of this entry »
Background and Consensus Guidelines
No general consensus exists as to which patients with blood clots and which family members should be tested for thrombophilias. At least five guidelines or consensus statements exist (ref 1-5). They vary markedly in their recommendations as to who should be tested and who not, Read the rest of this entry »